SCHEMBL4340976

SCHEMBL4340976

COc1cc2c(cc1C(=O)O)c(-c1cccc(F)c1)nn2C(NC(C)=O)C(N)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
CTSA P10619 3/20 0.37
CSNK1E P49674 2/20 0.36
PTGER1 P34995 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
CSNK1D P48730 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MAPK1 P28482 1/20 0.34
TACR3 P29371 5/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334488 0.89 PTGER1 (0.37) MAPTLMNACSNK1EPTGER1CSNK1D
SCHEMBL4334606 0.88 PTPN11 (0.41) CSNK1EPTGER1CSNK1DKDM4ETACR3
SCHEMBL4343214 0.82 CSNK1E (0.35) LMNACTSACSNK1EPTGER1ALDH1A1
SCHEMBL4334945 0.80 CSNK1E (0.38) CSNK1EPTGER1CSNK1DTACR3
SCHEMBL4343207 0.72 PTGER1 (0.38) CSNK1EPTGER1CSNK1DKDM4ETACR3
SCHEMBL4336324 0.72 PTGER1 (0.38) CSNK1EPTGER1CSNK1DKDM4ETACR3
SCHEMBL4332632 0.72 PTPN11 (0.41) CSNK1EPTGER1CSNK1DKDM4E
SCHEMBL4336462 0.71 CSNK1D (0.38) MAPTPTGER1HPGDCSNK1DKDM4E
SCHEMBL2864251 0.69 MAP2K4 (0.54) ALDH1A1HPGDKDM4EHSD17B10MAPK1
SCHEMBL4348125 0.68 PTGER1 (0.41) CSNK1EPTGER1ALDH1A1HPGDCSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPT 2644/4885LMNA 1893/4885CTSA 4048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.